Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:3342-3346
doi: 10.1161/CIRCULATIONAHA.105.551861
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lehnart, S. E.
Right arrow Articles by Marks, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lehnart, S. E.
Right arrow Articles by Marks, A. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Congestive
Right arrow Cardiovascular Pharmacology
Right arrow Arrythmias-basic studies
Right arrowRelated Article

(Circulation. 2005;111:3342-3346.)
© 2005 American Heart Association, Inc.


Editorial

Defective Ryanodine Receptor Interdomain Interactions May Contribute to Intracellular Ca2+ Leak

A Novel Therapeutic Target in Heart Failure

Stephan E. Lehnart, MD; Xander H.T. Wehrens, MD, PhD; Andrew R. Marks, MD

From the Clyde and Helen Wu Center for Molecular Cardiology, Department of Physiology and Cellular Biophysics (S.E.L., X.H.T.W., A.R.M.) and the Department of Medicine, College of Physicians and Surgeons (A.R.M.), Columbia University, New York, NY.

Correspondence to Dr Andrew R. Marks, Department of Physiology and Cellular Biophysics, College of Physicians and Surgeons, Columbia University, 630 West 168th St, Box 65, Room 9-401, New York, NY 10032. E-mail arm42@columbia.edu


Key Words: Editorials • calcium • death, sudden • heart failure • sarcoplasmic reticulum


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Heart failure (HF) is a leading cause of morbidity and mortality, and despite optimal medical treatment, patients with NYHA class III-IV symptoms have a 2-year mortality rate approaching 50%.1,2 About half of the deaths from HF occur suddenly,3,4 and ventricular arrhythmias account for a large percentage of these sudden cardiac deaths (SCDs).1 There is a strong correlation between chronic increased activity of the sympathetic nervous system (SNS) and poor prognosis in HF.5–7 Interestingly, ß-adrenergic receptor (ßAR) blockers that block the target receptors for catecholamines released during SNS activation reduce HF progression and arrhythmia vulnerability in patients with HF, leading to improved survival.8,9 Activation of the ßAR signaling cascade driven by the SNS caused by HF initially results in a compensatory response aimed at enhancing cardiac contractility, but when SNS activation is sustained, maladaptive changes occur.10 Chronic SNS activation desensitizes cardiac ßAR signaling,5 which further contributes to reduced inotropic reserve and worsens remodeling in HF, as part of a maladaptive response that ultimately fails to protect the heart or preserve cardiac function.11

See p 3400

Defective intracellular Ca2+ homeostasis has been consistently reported in HF.12,13 Because intracellular Ca2+ concentrations ([Ca2+]i) directly regulate contractility of cardiomyocytes, a reduced [Ca2+]i transient amplitude in HF results in decreased force development. A prolonged decay of the [Ca2+]i transient and increased diastolic [Ca2+]i may contribute to slowed relaxation of the failing heart.13–15 Several defects in the intracellular [Ca2+]i metabolism have been reported, including depressed Ca2+ uptake, storage, and/or release of . . . [Full Text of this Article]


Related Article:

Defective Regulation of Interdomain Interactions Within the Ryanodine Receptor Plays a Key Role in the Pathogenesis of Heart Failure
Tetsuro Oda, Masafumi Yano, Takeshi Yamamoto, Takahiro Tokuhisa, Shinichi Okuda, Masahiro Doi, Tomoko Ohkusa, Yasuhiro Ikeda, Shigeki Kobayashi, Noriaki Ikemoto, and Masunori Matsuzaki
Circulation 2005 111: 3400-3410. [Abstract] [Full Text]



This article has been cited by other articles:


Home page
J. Physiol.Home page
F. Joubert, J. R. Wilding, D. Fortin, V. Domergue-Dupont, M. Novotova, R. Ventura-Clapier, and V. Veksler
Local energetic regulation of sarcoplasmic and myosin ATPase is differently impaired in rats with heart failure
J. Physiol., November 1, 2008; 586(21): 5181 - 5192.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Hilfiker-Kleiner and R. Knoll
Disease-Modifying Mutations in Familial Hypertrophic Cardiomyopathy: Complexity From Simplicity
Circulation, April 8, 2008; 117(14): 1775 - 1777.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Liu and S. G. Priori
Disruption of calcium homeostasis and arrhythmogenesis induced by mutations in the cardiac ryanodine receptor and calsequestrin
Cardiovasc Res, January 15, 2008; 77(2): 293 - 301.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Curran, M. J. Hinton, E. Rios, D. M. Bers, and T. R. Shannon
{beta}-Adrenergic Enhancement of Sarcoplasmic Reticulum Calcium Leak in Cardiac Myocytes Is Mediated by Calcium/Calmodulin-Dependent Protein Kinase
Circ. Res., February 16, 2007; 100(3): 391 - 398.
[Abstract] [Full Text] [PDF]